An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
2 World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
3 Translational Genome Bioinformatics Laboratory, Moscow Institute of Physics and Technology (National Research University), Moscow, Russia.
4 Research Department, OmicsWay Corp., Walnut, CA, United States.
5 Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
6 Group for Experimental and Translational Radiooncology, Tyrolean Cancer Research Institute, Innsbruck, Austria.
7 PathoBiology Group, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
8 Department of Pathology & Laboratory Medicine, University of California Los Angeles (UCLA) Technology Center for Genomics & Bioinformatics, Los Angeles, CA, United States.
9 Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China.
1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
2 World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
3 Translational Genome Bioinformatics Laboratory, Moscow Institute of Physics and Technology (National Research University), Moscow, Russia.
4 Research Department, OmicsWay Corp., Walnut, CA, United States.
5 Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
6 Group for Experimental and Translational Radiooncology, Tyrolean Cancer Research Institute, Innsbruck, Austria.
7 PathoBiology Group, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
8 Department of Pathology & Laboratory Medicine, University of California Los Angeles (UCLA) Technology Center for Genomics & Bioinformatics, Los Angeles, CA, United States.
9 Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China.
Author AB was employed by the company OmicsWay Corp. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
Editorial on the Research Topic Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
References
Buzdin A, Sorokin M, Garazha A, Glusker A, Aleshin A, Poddubskaya E, et al. RNA sequencing for research and diagnostics in clinical oncology. Semin Cancer Biol (2020) 60:311–23. 10.1016/j.semcancer.2019.07.010
-
DOI
-
PubMed
Buzdin A, Sorokin M, Garazha A, Sekacheva M, Kim E, Zhukov N, et al. Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs. Semin Cancer Biol (2018) 53:110–24. 10.1016/j.semcancer.2018.06.003
-
DOI
-
PubMed
Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, et al. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med (2019) 25:751–8. 10.1038/s41591-019-0424-4
-
DOI
-
PMC
-
PubMed
Negro G, Aschenbrenner B, Brezar SK, Cemazar M, Coer A, Gasljevic G, et al. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities. Radiol Oncol (2020) 54:103–18. 10.2478/raon-2020-0007
-
DOI
-
PMC
-
PubMed
Skvortsova I. Special Issue “Enigmatic tumor properties associated with metastatic spread” seminars in cancer biology, volume XX. Semin Cancer Biol (2020) 60:iii–iv. 10.1016/j.semcancer.2019.10.021
-
DOI
-
PubMed